MET and lung cancer: For instance, in lung cancer, frequent mutations near the 5' and 3' splice sites of MET lead to exon 14 skipping, disrupting METΔ14 binding to CBL, thereby promoting MET protein stability and ultimately contributing to tumorigenesis 18, 19.